Breaking News
December 10, 2018 - Music improves social communication in autistic children
December 10, 2018 - Some Brain Tumors May Respond to Immunotherapy, New Study Suggests
December 10, 2018 - Banning junk food ads to combat childhood obesity
December 10, 2018 - Skin Autofluorescence Predicts T2DM, Heart Disease, Mortality
December 10, 2018 - Largest autism sequencing study to date yields 102 genes associated with ASD
December 10, 2018 - Statins associated with low risk of side effects
December 10, 2018 - Study explores how schools address adolescent self-harming practices
December 10, 2018 - Pregnancy in adolescence linked to increased risks of complications in young mothers
December 10, 2018 - Risk Analysis publishes special issue on communicating about Zika virus
December 10, 2018 - Botox May Help Prevent Post-Op A-Fib
December 10, 2018 - African-American mothers rate boys higher for ADHD
December 10, 2018 - Graphic warning labels cancel out cigarettes’ appeal to young people
December 10, 2018 - Australian researchers to study gas inhalational anaesthetic and likelihood of cancer return
December 10, 2018 - Individual neurons located within the brain have implications for psychiatric diseases
December 10, 2018 - Researchers improve bariatric surgery scoring system to extend prediction time for diabetic remission
December 10, 2018 - HPV type 16 or 18 associated with cervical cancer risk in young women
December 10, 2018 - Cervical cancer risk is higher in women with positive HPV, but no cellular abnormalities
December 10, 2018 - Combo therapy not needed if low RA disease activity achieved
December 10, 2018 - Novel therapeutic targets based on biology of aging show promise for Alzheimer’s disease
December 10, 2018 - UC San Diego professor receives NCI Outstanding Investigator Award for cancer research
December 10, 2018 - Study evaluates placental mesenchymal stem cell sheets for myocardial repair and regeneration
December 10, 2018 - Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis
December 10, 2018 - Study clarifies ApoE4’s role in dementia
December 10, 2018 - Eating disorders now a top priority with Australian Government
December 10, 2018 - Neuronal activity in the brain allows prediction of risky or safe decisions
December 10, 2018 - FDA Alerts Health Care Professionals and Patients Not to Use Drug Products Intended to be Sterile from Promise Pharmacy
December 10, 2018 - Improving dementia care and treatment saves thousands of pounds in care homes
December 10, 2018 - Heroin-assisted treatment can offer benefits, reduce harms
December 10, 2018 - People covered by Michigan’s expanded Medicaid program report improvements in health, finds study
December 10, 2018 - Hazelnuts improve micronutrient levels in older adults
December 9, 2018 - History of Partner Violence Tied to Menopause Symptoms
December 9, 2018 - Clean Up Safely After a Disaster|Natural Disasters and Severe Weather
December 9, 2018 - Drug wholesalers drove fentanyl’s deadly rise, report concludes
December 9, 2018 - Deprescribing could help manage polypharmacy in older adults
December 9, 2018 - Retraction of article “Joy of cooking too much” from journal
December 9, 2018 - FDA Warns of Rare Stroke Risk With MS Drug Lemtrada (Alemtuzumab)
December 9, 2018 - Feds say heroin, fentanyl remain biggest drug threat to US
December 9, 2018 - Eliminating microglia can reverse some aspects of stress sensitization, study shows
December 9, 2018 - New genetic insight could help treat rare debilitating heart and lung condition
December 9, 2018 - MiRagen Therapeutics Announces Final Safety, Biodistribution and Clinical Efficacy Data From Phase 1 Cobomarsen Clinical Trial in Patients With Mycosis Fungoides
December 9, 2018 - Work with your doctor to weigh pros, cons of treatment options for hyperthyroidism
December 9, 2018 - CWRU researcher secures $14.6 million funding for genetic study into Alzheimer’s disease
December 9, 2018 - High intensity statin treatment and adherence could save more lives
December 9, 2018 - Surgery patients use only 1/4 of prescribed opioids, and prescription size matters
December 9, 2018 - AXT offers Phi Optics upgrade to QPI systems for inverted light microscopes
December 9, 2018 - New booklet could help improve conditions of young pupils with albinism
December 9, 2018 - Few Physicians Work in Practices That Use Telemedicine
December 9, 2018 - Older Adults and Oral Health
December 9, 2018 - Health utility values improve after septorhinoplasty
December 9, 2018 - New EU-funded project provides insight into how the brain develops
December 9, 2018 - Expanded use of tele-emergency services can help strengthen rural hospitals
December 9, 2018 - Infections in the Young May Be Tied to Risk for Mental Illness: Study
December 9, 2018 - Profile: Native Hawaiians and Pacific Islanders
December 9, 2018 - Snoring poses greater cardiac risk to women
December 9, 2018 - Researcher takes further steps in understanding how and why cute aggression occurs
December 9, 2018 - Researchers create new light-activated tools for controlling neurons
December 9, 2018 - Spinal cord injury disrupts the body’s internal clock, study shows
December 9, 2018 - Babies recognize nested structures similar to our grammar
December 9, 2018 - UT Austin researcher receives $2.5 million CZI grant for neurodegenerative disease research
December 9, 2018 - Sleep problems found to be prevalent and increasing among college students
December 9, 2018 - Study reveals why some children are susceptible to the effects of maltreatment
December 9, 2018 - Study investigates influence of different opioids on driving performance
December 9, 2018 - Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia
December 9, 2018 - Eliminating microglia prevents heightened immune sensitivity after stress
December 9, 2018 - Boys with social difficulties are at greatest risk of early substance use
December 9, 2018 - ‘Wrong’ connective tissue cells linked to worse prognosis in breast cancer patients
December 8, 2018 - Chronic, refractory schizophrenia patients benefit from targeted cognitive training
December 8, 2018 - Advertising in kids’ apps more prevalent than parents may realize
December 8, 2018 - New way to trace the transmission histories of rare genetic diseases
December 8, 2018 - ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma
December 8, 2018 - Results of pediatric genomic epilepsy tests often reclassified
December 8, 2018 - New way of controlling HIV latency to completely eradicate the virus
December 8, 2018 - Phasefocus to showcase the Livecyte 2 at ASCB
December 8, 2018 - KHN’s ‘What the Health?’ Is health spending the next big political issue?
December 8, 2018 - Mussels take in microplastic pollution fibers and flush most of them out again
December 8, 2018 - AHA: How to Stop Smoking … for Good
December 8, 2018 - Scientists overturn odds to make Parkinson’s discovery
December 8, 2018 - Health benefits of producing marula vinegar
December 8, 2018 - Failure of critical cellular energy sensor responsible for CKD progression, study finds
December 8, 2018 - Ethnicity can be reliable indicator of gut microbiota diversity
Phonak expands its latest-generation Belong platform with Phonak Naída B, Phonak Sky B hearing aids

Phonak expands its latest-generation Belong platform with Phonak Naída B, Phonak Sky B hearing aids

image_pdfDownload PDFimage_print

Phonak, the leading global innovator for hearing instruments and wireless communication solutions, today announces the extension of its latest-generation Belong platform with Phonak Naída™ B and Phonak Sky™ B hearing aids. The addition of a lithium-ion rechargeable Naída B-R RIC, Sky B-PR and CROS B-R (a solution for single-sided deafness) further expands the company’s industry-leading portfolio of rechargeable hearing aids while bolstering its technology leadership position in the power and pediatric markets. Phonak is also announcing the debut of groundbreaking Roger™ MultiBeam Technology, available in the new Roger Select™ microphone as well as Roger Table Mic II. 

“Around the world, hearing care professionals trust Phonak to deliver innovative hearing solutions that solve even the most challenging situations,” said Thomas Lang, Senior Vice President of Phonak Marketing. “Today Phonak builds on this legacy of trust by introducing products that redefine expectations in power, pediatrics and Roger connectivity. Our now-complete Belong platform portfolio means professionals have the flexibility to offer the industry’s most comprehensive rechargeable suite of hearing solutions to ensure the best possible care.”

Phonak Naída B: Introducing the 5th generation of the world’s most trusted power hearing aid

According to the World Health Organization (WHO), approximately 36 million people worldwide live with severe to profound hearing loss. Left untreated, these individuals have extreme difficulty communicating with others, often relying on lip reading and/or sign language. One study found the societal costs of this degree of hearing loss in the U.S. alone to be nearly $300,000 over the lifetime of each person, most of this attributed to reduced work productivity.

The Phonak Naída B product portfolio was specifically developed to address the unique and complex challenges faced by this client group. Now in its 5th generation, Phonak Naída B provides the flexibility to meet these clients’ sound processing needs with an additional dedicated fitting formula – Adaptive Phonak Digital Contrast. In addition, Phonak Naída B default first fit provides the industry’s best Speech Intelligibility Index (SII) results for clients with severe to profound hearing loss and enhanced performance in noise when combined with Roger wireless solutions. For the first time, Naída comes in a rechargeable Receiver-in-Canal (RIC) option, offering the most feature-rich rechargeable hearing aid from Phonak, dedicated to users with severe to profound hearing loss.

Phonak Sky B: Unlocking a child’s full potential

Ears can be thought of as ‘doorways’ to the brain, and hearing loss as a ‘doorway problem’. A child’s growing brain must have access to clear and meaningful auditory information for timely language development and academic readiness. In fact, children need to hear approximately 45 million words by the age of 4 years to be ready for school.

Research tells us that providing children with optimal hearing solutions or ‘doorway opening devices’ from an early age directly impacts how well they will succeed.

With 45 years of experience developing life-changing hearing solutions for children, Phonak through the Sky B along with proven Roger technology opens obstructed ‘doorways’ and provides the clear sound quality needed to unlock children’s full potential and ensure they succeed.

The Sky B portfolio features AutoSense Sky OS, the only operating system built specifically for children, and SoundRecover2 which gives children access to a broader range of sounds essential for speech and language development. Phonak now offers a rechargeable option, Sky B-PR, that gives children a full day of uninterrupted hearing on a single charge.

MultiBeam Technology takes Roger to the next level

In 2013, Phonak introduced proprietary Roger 2.4 GHz wireless technology, setting a new benchmark for hearing in noise and over distance by transmitting a speaker’s voice directly to the listener. Five years later, the next generation of proven Roger performance and ease of use comes in the form of MultiBeam Technology (MBT). This technology uses three microphones to form six directional beams within 360 degrees. When a microphone with MBT is placed on a table, it automatically selects the speaker to improve the speech understanding in group conversations and noisy situations.

Roger Select™ and Roger Table Mic II are the first products to make use of MBT. Roger Select is a versatile microphone that uses MBT to help people with hearing loss hear better in noisy restaurants or other gatherings. Three distinct modes (automatic, manual, lapel) allow wireless hearing in a variety of conversations and environments. The Roger Table Mic II is the successor to the Roger Table Mic, now featuring MBT. The microphone is ideal for working adults who need to actively participate in meetings.

Also announced today is the Roger Repeater, which extends the operating range of any Roger network in the Roger for Education portfolio and is ideal for large school applications like auditoriums and gymnasiums.

The Phonak Naída B and Sky B will be available in the U.S. starting February 19th, with the rest of the world to follow in March. All new Roger products as well as CROS B-R will be available later in spring 2018.

Tagged with:

About author

Related Articles